Purchase Order 36C24920P0032
- Not listed
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The contract is for pathology lab consumable reagents and stains to support the VA's Veterans Integrated Service Network 19 located in Castleton, Indiana. The firm-fixed-price contract has a potential value of $180,394.20 and a completion date of...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 16 awarded a firm-fixed price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide reagents for a Roche Ventana Benchmark Special Tissue Stainer. The potential value of this contract is $122,694.43. This award does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, valued at $108,941.79, for the procurement of benchmark stainer reagents and consumables. This order was not set aside for any specific business type. Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment, has been a prime contractor and subcontractor providing critical care...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a $250,008.00 firm-fixed-price delivery order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The contract is for the provision of BENCHMARK IHC KITS, with a completion date of September 30, 2020. Roche Diagnostics has previously received awards from the VA, Department of Defense,...
- The Department of Veterans Affairs Veterans Health Administration awarded a $179,863.73 firm fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for the provision of benchmark reagents. This order was not set aside. Roche Diagnostics has a history of supplying critical care analyzers, reagents, test kits, and associated laboratory equipment and supplies to federal agencies such as the VA, Department of Defense, and Department of Health and...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and related laboratory equipment and supplies. The $176,874.00 contract provides reagents for use at VA facilities without any set-aside designation. Roche Diagnostics has held numerous federal contracts and subcontracts to supply critical care analyzers, test kits,...
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of benchmark reagents and supplies. The $302,163.51 contract does not have a set-aside designation. Roche Diagnostics, a foreign-owned for-profit manufacturer, has provided medical equipment, reagents, and laboratory supplies to various federal agencies through its General Services...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer. The $161,459.20 firm-fixed-price contract is for the annual requirement of VENTANA reagents, with a completion date of January 12, 2021. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and associated products and services to various...
- The Department of Veterans Affairs Veterans Health Administration awarded a Firm Fixed Price Delivery Order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of BENCHMARK REAGENT TEST KIT AND SUPPLIES. The contract has a potential value of $223,755.13 and a completion date of September 30, 2021. Roche Diagnostics, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments, has provided critical care...
- This firm fixed-price purchase order was awarded by the Department of Veterans Affairs (VA) to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $116,048.25 contract provides Roche Diagnostics' reagents for the VA's Veterans Health Administration facilities. Roche Diagnostics has a history of providing critical care medical equipment, reagents, and testing services to federal...
The Department of Veterans Affairs (VA) awarded a firm-fixed-price purchase order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, to provide benchmark ultra/special stains (reagents) for the James H. Quillen VA Medical Center in Castleton, Indiana. The $345,784.08 contract was awarded on October 1, 2019 with a completion date of March 16, 2021. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The company holds multiple General Services Administration (GSA) Schedule contracts and has a history of providing critical care analyzers, reagents, test kits, and other laboratory equipment, supplies, and services to various federal agencies, including the VA, Department of Defense, and Department of Health and Human Services. This award was not set aside for any specific business category.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Close Out | ($131k) | 3/16/21 | |
| P00002 | Funding Only Action | $226.0k | 5/20/20 | |
| P00001 | Funding Only Action | $16.1k | 1/31/20 | |
| Not listed | Not listed | $234.4k | 10/1/19 |